Hemoglobin-based oxygen carrier enhanced tumor oxygenation: A novel strategy for cancer therapy

Biotechnology Progress

Volumn 24, Issue 6, 2008, Pages 1353-1364

  Gundersen, Sharon I ^a,c   Palmer, Andre F ^b  

^a University of Notre Dame   (United States)

^b The Ohio State University   (United States)

^c Department of Chemical Engineering   (United States)

Author keywords

Hemoglobin based oxygen carriers; Oxygen carrier simulations; Oxygen transport; Tumor oxygenation

Indexed keywords

BLOOD STREAMS; CANCER THERAPIES; CANCER TREATMENTS; CANCEROUS TISSUES; CYLINDRICAL CAPILLARIES; HEMOGLOBIN-BASED OXYGEN CARRIERS; HUMAN BLOODS; LOW OXYGENS; NORMAL TISSUES; NOVEL STRATEGIES; OXYGEN AFFINITIES; OXYGEN CARRIER SIMULATIONS; OXYGEN DELIVERIES; OXYGEN TRANSPORT; RED BLOOD CELLS; TUMOR OXYGENATION;

BIOCHEMICAL OXYGEN DEMAND; BLOOD; HEMOGLOBIN; HISTOLOGY; MERCURY (METAL); ONCOLOGY; OXYGENATION; OXYGENATORS; TUMORS;

OXYGEN;

HEMOGLOBIN; HEMOGLOBIN GLUTAMER 200; HEMOGLOBIN GLUTAMER-200; OXYGEN;

ARTICLE; BIOLOGICAL MODEL; CHEMISTRY; HUMAN; METABOLISM; NEOPLASM; OXYGEN CONSUMPTION; TISSUE ENGINEERING;

HEMOGLOBINS; HUMANS; MODELS, BIOLOGICAL; NEOPLASMS; OXYGEN; OXYGEN CONSUMPTION; TISSUE ENGINEERING;

EID: 62249216370     PISSN: 87567938     EISSN: None     Source Type: Journal    
DOI: 10.1002/btpr.56     Document Type: Article

References (41)

1. Höckel M, Vaupel P. Tumor hypoxia: definitions and current clinical, biologic, and molecular aspects. J Natl Cancer Inst. 2001;93:266-276.
2. Kennedy KA, Teicher BA, Rockwell S, Sartorelli AC. The hypoxic tumor cell: a target for selective cancer chemotherapy. Biochem Pharmacol. 1980;29:1-8.
3. Teicher BA. Hypoxia and drug resistance. Cancer Metastasis Rev. 1994;13:139-168.
4. Harrison L, Blackwell K. Hypoxia and anemia: factors in decreased sensitivity to radiation therapy and chemotherapy? Oncologist. 2004;9:31-40.
5. Vaupel P. The role of hypoxia-induced factors in tumor progression. Oncologist 2004;9(Suppl 5):10-17.
6. Vaupel P, Harrison L. Tumor hypoxia: causative factors, compensatory mechanisms, and cellular response. Oncologist. 2004;9:4-9.
7. Pogue BW, O'Hara JA, Wilmot CM, Paulsen KD, Swartz HM. Estimation of oxygen distribution in RIF-1 tumors by diffusion model-based interpretation of pimonidazole hypoxia and Eppendorf measurements. Radiat Res. 2001;155:15-25.
8. Jordan BF, Sonveaux P, Feron O, Grégoire V, Beghein N, Gallez B. Nitric oxide-mediated increase in tumor blood flow and oxygenation of tumors implanted in muscles stimulated by electric pulses. Int J Radiat Oncol Biol Phys. 2003;55:1066-1073.
9. Chen Q, Huang Z, Chen H, Shapiro H, Beckers J, Hetzel FW. Improvement of tumor response by manipulation of tumor oxygenation during phootodynamic therapy. Photochem Photobiol. 2002;76:197-203.
10. Standl T, Horn P, Wilhelm S, Greim C, Freitag M, Freitag U, Sputtek A, Jacobs E, Esch JSA. Bovine haemoglobin is more potent than autologous red blood cells in restoring muscular tissue oxygenation after profound isovolaemic haemodilution in dogs. Can J Anaesth. 1996;43:714-723.
11. Nozue M, Lee I, Manning JM, Manning LR, Jain RK. Oxygenation in tumors by modified hemoglobins. J Surg Oncol. 1996;62:109-114.
12. Teicher BA, Ara G, Emi Y, Kakeji Y, Ikebe M, Maehara Y, Buxton D. RSR13: effects on tumor oxygenation and response to therapy. Drug Dev Res. 1996;38:1-11.
13. Teicher BA, Holden SA, Dupuis NP, Kusomoto T, Liu M, Liu F, Menon K. Oxygenation of the Rat-9L gliosarcoma and the Rat-13672 mammary-carcinoma with various doses of a hemoglobin solution. Artif Cells Blood Substit Immobil Biotechnol. 1994;22:827-833.
14. Teicher BA, Schwartz GN, Sotomayor EA, Robinson MF, Dupuis NP, Menon K. Oxygenation of tumors by a hemoglobin solution. J Cancer Res Clin Oncol. 1993;120:85-90.
15. Yu MH, Dai M, Liu Q, Xiu RJ. Oxygen carriers and cancer chemo- and radiotherapy sensitization: bench to bedside and back. Cancer Treatment Rev. 2007;33:757-761.
16. Teicher BA, Ara G, Herbst R, Takeuchi H, Keyes S, Northey D. PEG-hemoglobin: effects on tumor oxygenation and response to chemotherapy. In Vivo. 1997;11:301-311.
17. Teicher BA, Holden SA, Menon K, Hopkins RE, Gawryl MS. Effect of hemoglobin solution on the response of intracranial and subcutaneous 9L tumors to antitumor alkylating-agents. Cancer Chemother Pharmacol. 1993;33:57-62.
18. Linberg R, Conover CD, Shum KL, Shorr RGL. Increased tissue oxygenation and enhanced radiation sensitivity of solid tumors in rodents following polyethylene glycol conjugated bovine hemoglobin administration. In Vivo. 1998;12:167-173.
19. Robinson MF, Dupuis NP, Kusumoto T, Liu F, Menon K, Teicher BA. Increased tumor oxygenation and radiation sensitivity in 2 rat-tumors by a hemoglobin-based, oxygen-carrying preparation. Artif Cells Blood Substit Immobil Biotechnol. 1995;23:431-438.
20. Teicher BA, Holden SA, Ara G, Herman TS, Hopkins RE, Menon K. Effect of a bovine hemoglobin preparation (SBHS) on the response of 2 murine solid tumors to radiation-therapy or chemotherapeutic alkylating-agents. Biomater Artif Cells Immobilization Biotechnol. 1992;20:657-660.
21. Dimino ML, Palmer AF. Hemoglobin-based O-2 carrier O-2 affinity and capillary inlet pO(2) are important factors that influence O-2 transport in a capillary. Biotechnol Progr. 2007;23:921-931.
22. Gundersen SI, Palmer AF. Conjugation of methoxypolyethylene glycol to the surface of bovine red blood cells. Biotechnol Bioeng. 2007;96:1199-1210.
23. Patton JN, Palmer AF. Numerical simulation of oxygen delivery to muscle tissue in the presence of hemoglobin-based oxygen carriers. Biotechnol Progr. 2006;22:1025-1049.
24. Alayash AI, Summers AG, Wood F, Jia Y. Effects of glutaraldehyde polymerization on oxygen transport and redox properties of bovine hemoglobin. Arch Biochem Biophys. 2001;391:225-234.
25. Eike JH, Palmer AF. Effect of Cl and H on the oxygen binding properties of glutaraldehyde-polymerized bovine hemoglobin-based blood substitutes. Biotechnol Progr. 2004;20:1543-1549.
26. Eike JH, Palmer AF. Effect of glutaraldehyde concentration on the physical properties of polymerized hemoglobin-based oxygen carriers. Biotechnol Progr. 2004;20:1225-1232.
27. Eike JH, Palmer AF. Oxidized mono-, Di-, Tri-, and polysaccharides as potential hemoglobin cross-linking reagents for the synthesis of high oxygen affinity artificial blood substitutes. Biotechnol Progr. 2004;20:953-962.
28. 4 concentration and reaction time on physical properties of glutaraldehyde-polymerized hemoglobin. Biotechnol Progr. 2004;20:946-952.
29. Arifin DR, Palmer AF. Determination of size distribution and encapsulation efficiency of liposome-encapsulated hemoglobin blood substitutes using asymmetric flow field-flow fractionation coupled with multi-angle static light scattering. Biotechnol Progr. 2003;19:1798-1811.
30. Arifin DR, Palmer AF. Physical properties and stability mechanisms of poly(ethylene glycol) conjugated liposome encapsulated hemoglobin dispersions. Artif Cells Blood Substit Biotechnol. 2005;33:137-162.
31. Li SL, Nickels J, Palmer AF. Liposome-encapsulated actinhemoglobin (LEAcHb) artificial blood substitutes. Biomaterials. 2005;26:3759-3769.
32. Patton JN, Palmer AF. Engineering temperature-sensitive hydrogel nanoparticles entrapping hemoglobin as a novel type of oxygen carrier. Biomacromolecules. 2005;6:2204-2212.
33. Patton JN, Palmer AF. Photopolymerization of bovine hemoglobin entrapped nanoscale hydrogel particles within liposomal reactors for use as an artificial blood substitute. Biomacromolecules. 2005;6:414-424.
34. Patton JN, Palmer AF. Physical properties of hemoglobin-poly (acrylamide) hydrogel-based oxygen carriers: effect of reaction pH. Langmuir. 2006;22:2212-2221.
35. Fournier RL. Basic Transport Phenomena in Biomedical Engineering. Philadelphia, PA: Taylor & Francis, 1999.
36. Secomb, TW, Hsu R, Dewhirst MW, Klitzman B, Gross JF. Analysis of oxygen-transport to tumor-tissue by microvascular networks. Int J Radiat Oncol Biol Phys. 1993;25:481-489.
37. Krogh A. The number and distribution of capillaries in muscles with calculations of the oxygen pressure head necessary for supplying the tissue. J Physiol 1919;52:409-415.
38. Popel AS. Theory of oxygen transport to tissue. Crit Rev Biomed Eng 1989;17:257-321.
39. Popel AS, Goldman D, Vadapalli A. Modeling of oxygen diffusion from the blood vessels to intracellular organelles. In: Oxygen Transport to Tissue XXIV, Dunn JF, Swartz HM, Eds. Kluwer Academic/Plenum Publishers: New York, NY, 2003, Vol. 530, pp 485-495.
40. Vadapalli A, Goldman D, Popel AS. Calculation of oxygen transport by red blood cells and hemoglobin solutions in capillaries. Artif Cell Blood Substit Immobil Biotechnol. 2002;30:157-188.
41. Kavanagh BD, Secomb TW, Hsu R, Lin PS, Venitz J, Dewhirst MW. A theoretical model for the effects of reduced hemoglobin-oxygen affinity on tumor oxygenation. Int J Radiat Oncol Biol Phys 2002;53:172-179.